Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2Phase 3 1Phase 2 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 4

Conditions

Pancreatic Neoplasms 6Neoplasms 4Colorectal Neoplasms 4Stomach Neoplasms 3Glioma 2Weight Loss 1Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Solid Tumor 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Refractory Solid Tumors 1Recurrence 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pancreatic cancer, adult 1Pancreatic Diseases 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroblastoma 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasm Metastasis 1Metastatic Pancreatic Adenocarcinoma 1Mesothelioma 1Malignant Solid Neoplasm 1Head and Neck Neoplasms 1Gliosarcoma 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × irinotecan sucrosofate × Clear all
NCT05382559 2026-04-14

A Study of ASP3082 in Adults With Advanced Solid Tumors

Astellas Pharma Inc

Phase 1 Recruiting
681 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT00062842 2020-03-04

Study of Irinotecan on a Weekly Schedule in Children

Baylor College of Medicine

Phase 1 Completed
23 enrolled
Tumor-Agnostic

Neoplasms

NCT00364143 2019-07-05

Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors

Yakult Honsha Co., LTD

Phase 1 Completed
40 enrolled
Tumor-Agnostic

Neoplasms

NCT02640365 2017-01-31

DOUBLIRI

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 1 Completed
10 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡